Our mission: find solutions for hearing disorders

We are developing treatments which could revolutionize the care of patients with inner ear disorders

Our approach

A relentless search for innovation

Sensorion’s mission is to offer innovative therapeutic solutions providing long-term improvements to people living with, or at risk of, inner ear disorders. Sensorion’s portfolio of solutions to unmet medical and social needs in inner ear disorders rests on three pillars – Restore, Treat, Prevent.

Restore

We aim to restore hearing by treating genetic diseases previously regarded as untreatable.

Treat

We aim to treat hearing disorders through innovative small molecule therapeutic solutions.

Prevent

We aim to prevent non-genetic hearing loss (e.g drug or surgery-related) through targeted therapeutic programs.

Investors

A clear strategy around our 3 pillars - Restore, Treat, Prevent

With our partners, we are committed to building and developing a cutting-edge therapeutic portfolio for major causes of hearing loss.

More information

Discover our corporate presentation

Sensorion focuses on innovative treatments that can restore, treat and prevent hearing loss.

Download our corporate presentation

NEWS & EVENTS

Discover our latest news

February 19th, 2021

Sensorion presents new preclinical data on SENS-401 at ARO 2021

Read the release
February 17th, 2021

Sensorion announces that an Extraordinary General Meeting will be held behind closed doors on March 24, 2021

Read the release
February 17th, 2021

Sensorion : A Chardan Top Pick for 2021

Read the release

Our partners

Career

The beginning of a great journey

INVESTOR RELATIONS & COMMUNICATIONS MANAGER F/M

Entreprise Sensorion est une société de biotechnologie pionnière au stade clinique dédiée au développement de thérapies innovantes pour restaurer, traiter et prévenir dans le domaine des pertes d’audition. Un produit est en développement clinique de phase 2, le SENS-401 (Arazasétron) dans la perte auditive neurosensorielle soudaine (SSNHL). Nous avons développé dans nos laboratoires une plateforme […]

Discover
Ingénieur R&D Thérapie Génique F/H

Entreprise Sensorion est une société de biotechnologie pionnière au stade clinique dédiée au développement de thérapies innovantes pour restaurer, traiter et prévenir dans le domaine des pertes d’audition. Un produit est en développement clinique de phase 2, le SENS-401 (Arazasétron) dans la perte auditive neurosensorielle soudaine (SSNHL). Nous avons développé dans nos laboratoires une plateforme […]

Discover